| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C Capper-Loup, C M Frey, D Rebell, A Kaelin-Lan. Adaptive gene expression changes on the healthy side of parkinsonian rats. Neuroscience. vol 233. 2013-09-23. PMID:23270858. |
in addition, we analyzed the expression of several striatal and cortical glutamatergic markers, as well as nigral tyrosine hydroxylase (th) and nigral dopamine transporter (dat). |
2013-09-23 |
2023-08-12 |
rat |
| Adam W Oaks, Maya Frankfurt, David I Finkelstein, Anita Sidh. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. PloS one. vol 8. issue 4. 2013-09-16. PMID:23560093. |
young a53t mice had increased distribution of the dopamine transporter (dat) to the membrane that was associated with increased striatal re-uptake function. |
2013-09-16 |
2023-08-12 |
mouse |
| My Jonasson, Lieuwe Appel, Jonas Engman, Andreas Frick, Dag Nyholm, Håkan Askmark, Torsten Danfors, Jens Sörensen, Tomas Furmark, Mark Lubberin. Validation of parametric methods for [¹¹C]PE2I positron emission tomography. NeuroImage. vol 74. 2013-09-13. PMID:23435214. |
the radioligand [(11)c]pe2i is highly selective for dopamine transporter (dat) and can be used in vivo for investigation of changes in dat concentration, progression of disease and validation of treatment using positron emission tomography (pet). |
2013-09-13 |
2023-08-12 |
Not clear |
| My Jonasson, Lieuwe Appel, Jonas Engman, Andreas Frick, Dag Nyholm, Håkan Askmark, Torsten Danfors, Jens Sörensen, Tomas Furmark, Mark Lubberin. Validation of parametric methods for [¹¹C]PE2I positron emission tomography. NeuroImage. vol 74. 2013-09-13. PMID:23435214. |
dat is an important protein for regulation of central dopamine concentration and dat deficiency has been associated with several neurodegenerative and neuropsychiatric disorders. |
2013-09-13 |
2023-08-12 |
Not clear |
| Jackson J Cone, Elena H Chartoff, David N Potter, Stephanie R Ebner, Mitchell F Roitma. Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PloS one. vol 8. issue 3. 2013-09-12. PMID:23516454. |
prolonged high fat diet reduces dopamine reuptake without altering dat gene expression. |
2013-09-12 |
2023-08-12 |
rat |
| Jackson J Cone, Elena H Chartoff, David N Potter, Stephanie R Ebner, Mitchell F Roitma. Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PloS one. vol 8. issue 3. 2013-09-12. PMID:23516454. |
the development of diet-induced obesity (dio) can potently alter multiple aspects of dopamine signaling, including dopamine transporter (dat) expression and dopamine reuptake. |
2013-09-12 |
2023-08-12 |
rat |
| Jackson J Cone, Elena H Chartoff, David N Potter, Stephanie R Ebner, Mitchell F Roitma. Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PloS one. vol 8. issue 3. 2013-09-12. PMID:23516454. |
following diet exposure, rats were anesthetized with urethane and striatal dat function was assessed by electrically stimulating the dopamine cell bodies in the ventral tegmental area (vta) and recording resultant changes in dopamine concentration in the ventral striatum using fast-scan cyclic voltammetry. |
2013-09-12 |
2023-08-12 |
rat |
| Jackson J Cone, Elena H Chartoff, David N Potter, Stephanie R Ebner, Mitchell F Roitma. Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PloS one. vol 8. issue 3. 2013-09-12. PMID:23516454. |
our data provide further evidence for diet-induced alterations in dopamine reuptake independent of changes in dat production and demonstrates that such changes can manifest without the development of dio. |
2013-09-12 |
2023-08-12 |
rat |
| Mi-Ae Park, Stephen C Moore, Stefan P Müller, Sarah J McQuaid, Marie Foley Kijewsk. Performance of a high-sensitivity dedicated cardiac SPECT scanner for striatal uptake quantification in the brain based on analysis of projection data. Medical physics. vol 40. issue 4. 2013-09-11. PMID:23556920. |
datscan (isoflupane i-123) is a dopamine transporter (dat) imaging agent that has shown potential for early detection of parkinson disease (pd), as well as for monitoring progression of the disease. |
2013-09-11 |
2023-08-12 |
Not clear |
| Jerome A Roth, Zhezheng Li, Swetha Sridhar, Habibeh Khoshboue. The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. Neurotoxicology. vol 35. 2013-09-10. PMID:23313730. |
the effect of manganese on dopamine toxicity and dopamine transporter (dat) in control and dat transfected hek cells. |
2013-09-10 |
2023-08-12 |
Not clear |
| Jerome A Roth, Zhezheng Li, Swetha Sridhar, Habibeh Khoshboue. The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. Neurotoxicology. vol 35. 2013-09-10. PMID:23313730. |
although dopaminergic neurons within the nigrostriatal pathway appear intact, mn-induced irregularities in da transmission have been observed including decreased amphetamine-induced da release and loss of the dopamine transporter (dat). |
2013-09-10 |
2023-08-12 |
Not clear |
| Morten Ziebell, Birgitte B Andersen, Lars H Pinborg, Gitte M Knudsen, Jette Stokholm, Gerda Thomsen, Merete Karlsborg, Peter Høgh, Mette Louise Mørk, Steen G Hasselbalc. Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 54. issue 7. 2013-09-10. PMID:23637201. |
in this study, we correlated the core features of dlb (dementia, parkinsonism, hallucinations, and fluctuations) with striatal dopamine transporter (dat) availability as assessed with spect and (123)i-n-(3-iodoprop-2e-enyl)-2-β-carbomethoxy-3β-(4-methylphenyl) nortropane ((123)i-pe2i) in patients with newly diagnosed dlb. |
2013-09-10 |
2023-08-12 |
Not clear |
| Razieh Samandari, Atieh Chizari, Rezvan Hassanpour, Zahra Mousavi, Abbas Haghparas. Streptozotocin-induced diabetes affects the development and maintenance of morphine reward in rats. Neuroscience letters. vol 543. 2013-09-06. PMID:23545208. |
it affects brain reward pathways through regulation of the dopamine (da) transporter (dat). |
2013-09-06 |
2023-08-12 |
rat |
| F Mignini, M Sabbatini, M Capacchietti, C Amantini, E Bianchi, M Artico, A Tammar. T-cell subpopulations express a different pattern of dopaminergic markers in intra- and extra-thymic compartments. Journal of biological regulators and homeostatic agents. vol 27. issue 2. 2013-09-04. PMID:23830396. |
the present study was designed to characterize dopamine plasma membrane transporter (dat), vesicular dopamine transporters (vmat)-1 and -2, and dopamine d1-like and d2-like receptors in rat thymocytes, splenocytes and peripheral blood mononuclear cells. |
2013-09-04 |
2023-08-12 |
rat |
| F Mignini, M Sabbatini, M Capacchietti, C Amantini, E Bianchi, M Artico, A Tammar. T-cell subpopulations express a different pattern of dopaminergic markers in intra- and extra-thymic compartments. Journal of biological regulators and homeostatic agents. vol 27. issue 2. 2013-09-04. PMID:23830396. |
furthermore facs analysis, indicates that dat and dopamine d1-like receptors are expressed at high levels in thymocytes, splenocytes, and peripheral lymphocytes. |
2013-09-04 |
2023-08-12 |
rat |
| Sucharita S Somkuwar, Mahesh Darna, Kathleen M Kantak, Linda P Dwoski. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood. Biochemical pharmacology. vol 86. issue 2. 2013-09-03. PMID:23623751. |
methylphenidate, an inhibitor of dopamine and norepinephrine transporters (dat and net, respectively), is a standard treatment for adhd. |
2013-09-03 |
2023-08-12 |
rat |
| Sucharita S Somkuwar, Mahesh Darna, Kathleen M Kantak, Linda P Dwoski. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood. Biochemical pharmacology. vol 86. issue 2. 2013-09-03. PMID:23623751. |
in both ofc and mpfc, no strain differences in vmax or km for dopamine uptake into synaptosomes were found between vehicle-treated shr, wky and wis. methylphenidate increased dat vmax in shr mpfc and decreased dat vmax in wky ofc. |
2013-09-03 |
2023-08-12 |
rat |
| Nicholas V Cozzi, Simon D Brandt, Paul F Daley, John S Partilla, Richard B Rothman, Andreas Tulzer, Harald H Sitte, Michael H Bauman. Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. European journal of pharmacology. vol 699. issue 1-3. 2013-09-02. PMID:23178523. |
at the norepinephrine and dopamine transporters (net and dat), all tfmap isomers were less potent than methcathinone as uptake inhibitors and releasers. |
2013-09-02 |
2023-08-12 |
rat |
| Kyle C Schmitt, Richard B Rothman, Maarten E A Reit. Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates. The Journal of pharmacology and experimental therapeutics. vol 346. issue 1. 2013-08-30. PMID:23568856. |
the dopamine transporter (dat) is a sodium-coupled symporter protein responsible for modulating the concentration of extraneuronal dopamine in the brain. |
2013-08-30 |
2023-08-12 |
Not clear |
| Kyle C Schmitt, Richard B Rothman, Maarten E A Reit. Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates. The Journal of pharmacology and experimental therapeutics. vol 346. issue 1. 2013-08-30. PMID:23568856. |
whereas inhibitors block monoamine uptake by the dat but are not translocated across the membrane, substrates are actively translocated and trigger dat-mediated release of dopamine by reversal of the translocation cycle. |
2013-08-30 |
2023-08-12 |
Not clear |